New Mexico INBRE Success Stories

Congratulations to Dr. Gayan Rubasinghege on his promotion to Associate Professor!

Gayan Rubansighege

We are excited to announced that Dr. Gayan Rubasinghege, current New Mexico INBRE investigator has been promoted to Associate Professor. Dr. Rubasinghege received his Ph.D. in Physical and Environmental Chemistry from the University of Iowa in 2011.  He’s currently a Chemistry Assistant Professor at New Mexico Tech.  As a New Mexico INBRE investigator, Dr. Rubasinghege has been able to excel his research and professional development skills.  His current research revolves around nanomaterial, polymer composite and environmental chemistry, studying hidden reaction pathways and mechanisms in environmental processes to better understand the impact of mineral oxides and engineered nanoparticles on poorly understood environmental process. For more information on Dr. Gayan Rubasinghege and his research, click here.

 

 


NM-INBRE Science Advisor Dr. Vallabh “Raj” Shah has been awarded a 5-year $3.5 million grant by the NIH to study kidney cancer 

Vallabh “Raj” Shah, PhD, Distinguished and Regents’ Professor in The University of New Mexico’s Departments of Biochemistry & Molecular Biology and Internal Medicine, and Mark Unruh, MD, chair of Internal Medicine, will study risk factors for chronic kidney disease (CKD) among Native Americans in the southwestern U.S. to determine whether any progress is being made

Shah — who has worked with Native Americans for more than 25 years — and Unruh formed a consortium of investigators with extensive experience in studying chronic diseases, including diabetes and kidney disease.

The National Institutes of Health (NIH) recently announced a five-year $3.5 million grant to fund the consortium in hopes of improving the understanding of potential risk factors for CKD and cardiovascular disease progression, as well as the impact of the disease among Native Americans.  Read More


New Mexico INBRE investigator Dr. Kevin Houston has been awarded $1 million by the NIH

New Mexico INBRE investigator Dr. Kevin Houston has been awarded a $1 million, four-year grant from the National Institutes of Health (NIH) to investigate how GPER1-dependent mechanisms of tamoxifen action contribute to tamoxifen resistance in breast cancer cells. 

The goal of this multiyear study entitled “GPER1-Dependent Regulation of IGF-1R in Tamoxifen Treated Breast Cancer Cells” is to further characterize how GPER1 is involved in the development of tamoxifen resistance in breast cancer cells and to identify potential targets for future design of pharmaceutical treatments that can lessen the likelihood that resistance will develop in breast cancer patients that are treated with tamoxifen.

In addition, this funding will provide the resources necessary to encourage and support both undergraduate and graduate students in research training while they are completing their studies at NMSU. 


CONGRATULATIONS TO OUR NM-INBRE INVESTIGATOR RODOLFO TELLO-ABURTO

Congratulations to Dr. Rodolfo Tello-Aburto, one of our INBRE investigators for recently receiving federal funding by NIH for his R15 entitled “Structure-Activity Relationship Studies of Peptide Beta-Lactones as Proteasome Inhibitors and Anticancer Agents“.